Molecular connectivity to find β-blockers with low toxicity

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 5, 1997, Pages 567-572

  Garcia Domenech, R ^a   De Gregorio Alapont, C ^a   De Julian Ortiz J V ^a   Galvez J ^a   Popa, L ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ALPRENOLOL; AROTINOLOL; ATENOLOL; BEFUNOLOL; BEFURAROL; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA CAROTENE; BETAXOLOL; BOPINDOLOL; BUCUMOLOL; BUFETOLOL; BUNITROLOL; BUTRIDINE; CARTEOLOL; CELIPROLOL; INDENOLOL; LABETALOL; LEVOBUNOLOL; METIPRANOLOL; METOPROLOL; NADOLOL; NADOXOLOL; NIPRADILOL; PROBUCOL; PRONETALOL; TALINOLOL; TIMOLOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; DISCRIMINANT ANALYSIS; DRUG CONFORMATION; DRUG RECEPTOR BINDING; DRUG TOXICITY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; THEORY;

EID: 0031552160     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00046-2     Document Type: Article

References (22)

1. 1. Kier, L. B.; Hall, L. H. Molecular Connectivity in Structure-Activity Analysis, Research Studies Press. Letchworth, England, 1986; pp 225-246.
2. 2. Garcia, R ; Gálvez, J.; Moliner, R.; García, F. Drug Invest. 1991, 3, 344.
3. 3. Julián-Ortiz, J. V. de ; García-Domenech, R.; Galvez, J. J. Chromatogr. 1996, 719, 37.
4. 4. Muñoz, C.; Julian-Ortiz, J. V. de ; Gimeno, C.; Catalán, V.; Galvez, J. Rev. Esp. Quimioter. 1994, 7, 279.
5. 5. Gálvez, J.; Garcia. R.; Julian-Ortiz, J. V. de ; Soler, R. J. Chem. Inf. Comput. Sci. 1995, 35, 272.
6. 6. Antón-Fos, G. M.; García-Domenech, R.; Perez-Gimenez, F.; Peris-Ribera, J. E.; García-March, F. J.; Salabert-Salvador, M. T. Arzneim-Forsch/Drug Res. 1994, 44, 821.
7. 7. Gálvez, J.; Garcia, R.; Julián-Ortiz, J. V. de ; Soler, R. J. Chem. Inf. Comput. Sci. 1994, 34, 1198.
8. 8. García-Domenech, R.; García-March, F. J.; Soler, R.; Galvez, J.; Antón-Fos, G. M.; Julián-Ortiz, J. V. de Quant. Struct.-Act. Relat. 1996, 15, 201.
9. 9. Kier, L. B.; Hall, L. H. Eur. J. Med. Chem. 1977, 12, 313.
10. 10.Wiener, H. J. Am. Chem. Soc. 1947, 69, 2636.
11. 11.Galvez, J.; García-Domenech, R.; Salabert, M. T.; Soler, R. J. Chem. Inf. Comput. Sci. 1994, 34, 520.
12. 12.Moliner, R.; García, F.; Gálvez, J.; García-Domenech, R.; Serrano, C. An. R. Acad. Farm.1991, 57, 287.
13. 13.Dixon, W. J.: BMDP Statistical Software. Berkeley, University of California, USA 1990.
14. 14.Cobbe, S. M.; Alexopoulos, D. Eur. Heart. J. 1988, 9, 24.
15. 15.Sasaki, N.; Saku, K. Artery. 1993, 20, 115.
16. 16.Murray, R.; Keenan, A. K. Cell-Signal. 1989, 1, 173.
17. 17.Gilligan, D. M.; Sack, M. N. J. Am. Coll. Cardiol. 1994, 247, 1611.
18. 18.Curt, D. Pharmedicum 1996, 4, 15.
19. 19.Lebeau, J. E. Nouv. Presse Med. 1980, 9, 3001.
20. 20.Weissmann, G.; Pras, M.; Rosenberg, L. Arthritis Reum. 1967, 10, 325.
21. 21.The Merck Index., Merck & CO., Inc. Rahway, N. J. USA, Eleventh Edition, 1989.
22. 22.AHES Drug Information, American Hospital Formulary Service, Bethesda, 1993, pp 896.